About this trial
The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are:
1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to address acetabular labral pathologies? 2. Does PRP/PPP/BMAC application reduce the arthritic burden as measured by functional outcomes following hip arthroscopy to address labral pathologies with concomitant PRP/PPP/BMAC application?
Eligibility criteria
Qualifiers
Age: > or equal to 18 years
Clinically indicated for hip arthroscopy (by the study PI) to address a labral pathology
Willingness to participate, amenable to randomization into either treatment arm of the research study, and the ability to understand & sign the informed consent document
Disqualifiers
Non-English speaking (PROM surveys are only validated in English)
Prior same site (i.e., ipsilateral hip) surgery, including but not limited to previous hip arthroscopy, core decompression, or periacetabular osteotomies
Trial design
Treatments tested in this trial
- Bone marrow aspirate concentrate (BMAC)
- Control